Member Info for spike912

Given we were 30-40p pre CRL, you’d like to think we would be as a minimum 50p on a positive result. The reason I think we may struggle for more is due to a number of sellers after buying in at these prices coupled with the funding to take to market But once you have an approved drug with further potential applications, regardless of your strategy, your onto a very lucrative winner imo

Kettle, I would imagine, as would any good business, that they would have a plan with various permutations dependent on the minutes. That said, they won’t be sharing any with us until formal minutes are issued They can’t show us a path forward until they understand the outcome from the type A meeting, but they would, imo, have a plan in their mind It’s just a waiting game now Remember they could go back for further details and clarity once the minutes are received so I wouldn’t be getting too concerned if there is a slight wait. Let’s not forget they have to digest the detail, fine tune the forward plan, get nomad sign off amongst others, before we even see it via an RNS. So that could easily be a week imo

Thanks Ivy. Tend to agree, and you’d hope any additional funding would be at a premium to today’s price and most would be comfortable if it was required for something like commerciality progress and benefits shareholders But imo a fair few would have bailed by then on the good news Worst fear is poor results and funding at lower levels but listening to the bod seems unlikely to be share tanking terrible news from these prices

Well I hope it’s good news as I’m moving and getting married in two weeks and need cash so gone balls deep. It’s roulette here for me, just hope my number comes in! 214k shares here, sadly a chunk at a lot higher average pre CRL but averaged down nicely Squeaky bum time now

No as it’s got Flybe 2.0 written all over it

Should just be bullet point format back from FDA unless they have gone back for clarity on content, which they can of course do under the guidelines.

Too many big sells for that dropping bid on each one. Wouldn’t be action like this to collect shares imo

Something not right imo. Amount of sells, price falling big time

Just looked on twitter It appears all tweets been deleted in relation to the rumour including the tweet from the pharma company

All these little round 2000-4000 sells

SP250, i don’t think you can say too much about negativity here lol. Ask is dropping on buys so potentially a sell in the system If the rumour was right we would be flying. If some odd ****ter had the news the market certainly would have. The tweet also doesn’t say it’s the results, it says IF labeling only issue, new NDA would be needed. It’s a clever tweet that’s all

Sell not well

Would think well being worked given dropping on buys

Not sure what to believe but guy on twitter did call this a week or so ago to be fair then post was deleted

Haha Classic

Jay_P nothing to do with luck. It’s called researched and reading the RNS and not believing the same nonsense of people saying 1p plus today. But hey, let’s not tar them with the same brush as someone who actually calls it right based on knowledge...let’s just filter and call him a deramper

Means nadda until contacts land in an RNS, look at bbsn print example

LB pure speculation based on very little unless you known their margins before any of us Flat finish on the cards imo

It’s also worth noting, even if the company receives the minutes on day 30, they would then likely need to review internally, produce the RNS, nomad sign off etc Imo we won’t see an RNS until end of this week very early next. They won’t rush it out on the day it’s received Best case, they have three days to issue price sensitive news, so my guess is end of week, but that wouldn’t be the best idea imo, Friday’s are bad news days, so I will stick my hat in the ring for Monday next week Very high risk, very high reward Approval we could be anywhere between 50p-£1 imo

Doh! Sorry my bad!! Monday mornings and lack of coffee! Just read the latest results and seems such high potential here when you compare with the likes of SOLG, mcap is unbelievably undervalued imo